Showing results (21-30 of 163) with videos related to

Sort By:
Pageof 17
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 1, 2013
Introducing the composite time trade-off: a test of feasibility and face validityBas M F Janssen, Mark Oppe, Matthijs M Versteegh, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 24, 2012
[A man who could only sleep sitting]Renske J Schimmel, Jan Stolk, Michel I M Versteegh, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2022
Effectiveness and Cost-Effectiveness of 360 Disease-Modifying Treatment Escalation Sequences in Multiple SclerosisMatthijs M Versteegh, Simone A Huygens, Beatrijs W H Wokke, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 9, 2006
[Pulmonary sequestrum--not infiltrate--in a 45-year-old woman]E E L O Lashley, M I M Versteegh, R Smithuis, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Condition-specific preference-based measures: benefit or burden?Matthijs M Versteegh, Annemieke Leunis, Carin A Uyl-de Groot, et al.
Interactive Cardiovascular and Thoracic Surgery|September 18, 2008
Should amiodarone or lidocaine be given to patients who arrest after cardiac surgery and fail to cardiovert from ventricular fibrillation?Boudewijn P J Leeuwenburgh, Michael I M Versteegh, Jacinta J Maas, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 11, 2012
[Performance indicators for hospitals]Sabrina Siregar, Rolf H H Groenwold, Michel J M Versteegh, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 1, 2013
Time to tweak the TTO: results from a comparison of alternative specifications of the TTOMatthijs M Versteegh, Arthur E Attema, Mark Oppe, et al.
Pageof 17